Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer. Verismo’s cellular therapy, known as KIR-CAR, is designed to provide a “natural stimulation” to T cells…
Employbl doesn’t track Verismo Therapeutics’s job board yet, so there’s nothing to show here — they may still be hiring. You can also search all jobs →
Siegel OilEquipment Savers Fleet ServicesColorado Advisory BoardVerismo TherapeuticsUniversity of the Pacific
Bryan Kim
CEO at Verismo Therapeutics
Transcure Bio VenturesVerismo TherapeuticsHipset
Michael Milone
Researcher
Cabaletta BioVerismo TherapeuticsPerelman School of MedicinePenn Medicine University of Pennsylvania Health SystemHome DepotUniversity of Pennsylvania (Penn)Rutgers New Jersey Medical SchoolUMDNJ – Graduate School of Biomedical SciencesStevens Institute of TechnologyUniversity of Pennsylvania (Penn)